Abstract:BACKGROUND: The kinesin family member 20a (KIF20A) protein has been implicated in the development and progression of many human cancers; however, its precise function and role in cervical cancer remain largely unclear. This study aimed to investigate the expression profile and prognostic value of KIF20A in patients with early-stage cervical squamous cell carcinoma.METHODS: We examined the mRNA and protein levels of KIF20A in eight cervical cancer cell lines and eight paired cervical cancer samples, compared with normal cervical epithelial cells and adjacent normal cervical tissues, respectively. Immunohistochemistry was performed to detect the expression of KIF20A in paraffin-embedded specimens from 169 early-stage cervical squamous cell carcinoma patients. Statistical analyses were applied to analyze the association between KIF20A expression and clinical variables, as well with patient survival.RESULTS: The mRNA and protein expression levels of KIF20A were significantly elevated in cervical cancer cell lines and lesions compared with normal cells and corresponding normal tissues (P < 0.05). Immunohistochemistry analysis in 169 cervical cancer cases revealed that increased KIF20A expression was strongly associated with human papillomavirus (HPV) infection (P = 0.008), clinical stage (P = 0.001), tumor recurrence (P = 0.016), vital status (P < 0.001), the property of the surgical margin (P = 0.032), the lymphovascular space involvement (P = 0.014), and pelvic lymph node metastasis (P = 0.001). The overall survival and disease-free survival of patients with high levels of KIF20A expression were significantly poorer than those with low KIF20A expression. KIF20A was an independent survival prognostic factor, as evidenced by univariate and multivariate analysis.CONCLUSIONS: Our results illustrate that elevated KIF20A expression correlates with HPV infection, clinical stage, tumor recurrence, lymphovascular space involvement, pelvic lymph node metastasis, and poor outcome in early-stage cervical squamous cell carcinoma patients. KIF20A aberrant expression is a novel independent unfavorable prognostic factor and may present a potential therapeutic target for cervical cancer.

Increased Kif15 Expression Predicts A Poor Prognosis In Patients With Lung Adenocarcinoma

High expression of KIFC1 is a poor prognostic biomarker and correlates with TP53 mutation in lung cancer

Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis

The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer.

Loss of LIMCH1 Predicts Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics

Aurka, Dlgap5, Tpx2, Kif11 And Ckap5: Five Specific Mitosis-Associated Genes Correlate With Poor Prognosis For Non-Small Cell Lung Cancer Patients

An evaluation of KIF20A as a prognostic factor and therapeutic target for lung adenocarcinoma using integrated bioinformatics analysis

KIF5B-RET fusions in Chinese patients with non-small cell lung cancer.

Identification of Genes Associated with Lung Adenocarcinoma Prognosis

KIF15 Contributes to Cell Proliferation and Migration in Breast Cancer

Kinesin family member 2A high expression correlates with advanced tumor stages and worse prognosis in non-small cell lung cancer patients

Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma

Preliminary Study on the Clinical Significance of Kinesin Kif18a in Nonsmall Cell Lung Cancer: an Analysis of 100 Cases.

Co-expression Network Analysis Identified KIF2C in Association with Progression and Prognosis in Lung Adenocarcinoma.

Expression of KIF23 and Its Prognostic Role in Non-small Cell Lung Cancer:Analysis Based on the Data-mining of Oncomine

Increased Expression of KNSTRN in Lung Adenocarcinoma Predicts Poor Prognosis: A Bioinformatics Analysis Based on TCGA Data

KIF11 is a Potential Prognostic Biomarker and Therapeutic Target for Adrenocortical Carcinoma

KIF5A upregulation in hepatocellular carcinoma: A novel prognostic biomarker associated with unique tumor microenvironment status

Expression of KIAA1456 in Lung Cancer Tissue and Its Effects on Proliferation, Migration and Invasion of Lung Cancer Cells

KIAA0101 as a new diagnostic and prognostic marker, and its correlation with gene regulatory networks and immune infiltrates in lung adenocarcinoma

High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma